| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 41,181 | 28,219 | 29,348 | 33,799 | | Cost of Revenue | 34,383 | 25,354 | 27,295 | 30,919 | | | Gross Profit | 6,798 | 2,865 | 2,053 | 2,880 | | | Operating Expenses | | Research Development |
-
| 5,684 | 7,175 | 6,669 | | Selling General and Administrative | 6,199 |
-
|
-
|
-
| | Non Recurring | (220) |
-
|
-
|
-
| | Others |
-
|
-
| 500 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 819 | (2,819) | (5,622) | (3,789) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 451 | 39 | 195 | 841 | | Earnings Before Interest And Taxes | 1,270 | (2,593) | (4,924) | (2,655) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,270 | (2,593) | (4,924) | (2,655) | | Income Tax Expense | 341 | (498) | (2,092) | (1,422) | | Minority Interest | 14 | 187 | 503 | 293 | | | | Net Income From Continuing Ops | 943 | (2,095) | (2,832) | (1,233) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 943 | (2,095) | (2,832) | (1,233) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $943 | ($2,095) | ($2,832) | ($1,233) |
|
0.59% Nasdaq 
0.10 (0.56%) 
Income Statement
